###begin article-title 0
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Identification and targeted disruption of the mouse gene encoding ESG1 (PH34/ECAT2/DPPA5)
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG</italic>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 234 239 <span type="species:ncbi:10090">mouse</span>
Embryonic stem cell-specific gene (ESG) 1, which encodes a KH-domain containing protein, is specifically expressed in early embryos, germ cells, and embryonic stem (ES) cells. Previous studies identified genomic clones containing the mouse ESG1 gene and five pseudogenes. However, their chromosomal localizations or physiological functions have not been determined.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 383 388 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 741 745 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 745 749 742 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 809 813 806 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 813 817 810 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
A Blast search of mouse genomic databases failed to locate the ESG1 gene. We identified several bacterial artificial clones containing the mouse ESG1 gene and an additional ESG1-like sequence with a similar gene structure from chromosome 9. The ESG1-like sequence contained a multiple critical mutations, indicating that it was a duplicated pseudogene. The 5' flanking region of the ESG1 gene, but not that of the pseudogene, exhibited strong enhancer and promoter activity in undifferentiated ES cells by luciferase reporter assay. To study the physiological functions of the ESG1 gene, we replaced this sequence in ES cells with a beta-geo cassette by homologous recombination. Despite specific expression in early embryos and germ cells, ESG1-/- mice developed normally and were fertile. We also generated ESG1-/- ES cells both by a second independent homologous recombination and directly from blastocysts derived from heterozygous intercrosses. Northern blot and western blot analyses confirmed the absence of ESG1 in these cells. These ES cells demonstrated normal morphology, proliferation, and differentiation.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse ESG1 gene, together with a duplicated pseudogene, is located on chromosome 9. Despite its specific expression in pluripotent cells and germ cells, ESG1 is dispensable for self-renewal of ES cells and establishment of germcells.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 702 703 702 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 704 705 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 92 98 <span type="species:ncbi:9606">humans</span>
###xml 309 314 <span type="species:ncbi:10090">mouse</span>
###xml 402 407 <span type="species:ncbi:9606">human</span>
Embryonic stem (ES) cells were first derived from the blastocysts of mice in 1981 [1,2] and humans in 1998 [3]. ES cells have two important properties: theability to maintain pluripotency, which is the ability to differentiate into a wide variety of cells, and rapid proliferation. These characteristics make mouse ES cells an essential component of gene targeting technology. These qualitiesalso make human ES cells attractive sources for cell transplantation therapy to treat various diseases, including spinal cord injuries and juvenile diabetes. The molecular mechanisms underlying the pluripotency and rapid proliferation of ES cells are currently a major focus of the field of stem cell biology [4-6].
###end p 9
###begin p 10
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 367 373 367 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dppa5 </italic>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ECAT2</italic>
To identify molecules essential in ES cells for these properties, several groups have utilized transcriptome analyses to identify genes specifically expressed in ES cells and early embryos. These analyses, including DNA microarray analyses [7] and expressed sequence tag analyses [8-12], identified several common transcripts, including ESG1 that was also designated dppa5 or ECAT2.
###end p 10
###begin p 11
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
ESG1 was originally identified as a transcript Ph34 that was down-regulated by retinoic acid in embryonic carcinoma cells [13]. The expression of this gene was confined in mice to early embryos and germ cells [14]. It is also expressed in pluripotent cells, including ES cells, embryonic germ cells, and multipotent germline stem cells [15]. ESG1 encodes a polypeptide of 118 amino acids that contains a single KH domain, which is an RNA-binding domain [16]. It remains unclear, however, if ESG1 functions as an RNA-binding protein or the roles it plays in ES cells and mice.
###end p 11
###begin p 12
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
###xml 432 437 <span type="species:ncbi:10090">mouse</span>
Previous genomic library screening by identified genomic clones containing the mouse ESG1 gene and seven pseudogenes [17]. Two of these pseudogenes exhibit a similar exon-intron structure as the ESG1 gene, indicating their generation by gene duplication. The five remaining pseudogenes did not contain any introns, indicating that these were generated by retrotransposition of ESG1 transcripts. The chromosomal localizations of the mouse ESG1 gene and pseudogenes, however, have not been reported.
###end p 12
###begin p 13
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
In this study, we determined the structure of the mouse gene encoding this protein and related pseudogenes. We also performed gene targeting to determine the physiological function of ESG1.
###end p 13
###begin title 14
Results and discussion
###end title 14
###begin title 15
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
Chromosomal localization and structures of mouse ESG1 gene and psedogenes
###end title 15
###begin p 16
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 487 492 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 770 772 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
To determine the chromosomal localizations of the mouse ESG1 gene and pseudogenes, we performed a Blast analysis of the mouse genomic database with the ESG1 cDNA sequence as a query. We identified several putative pseudogenes without introns on chromosomes 1, 5, 11, 12, 14, 16, 17, and X (Figure 1). In addition, two intron-less pseudogenes were identified in DNA fragments for which the chromosomal localization remained unmapped. While these pseudodgenes have significant homology to ESG1 cDNA, they could not produce functional proteins, because of critical mutations. This result suggests that there are a larger number of intron-less pseudogenes than previously anticipated. Existence of multiple retropseudogenes is a hallmark of pluripotent cell-specific genes [18].
###end p 16
###begin p 17
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ESG1</italic>pseudogenes identified by a Blast search of mouse genomic databases</bold>
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
ESG1pseudogenes identified by a Blast search of mouse genomic databases. Substitution mutations are indicated by black lines. Intron-like gap sequences are indicated with triangles. Chromosomal localizations are shown on the right.
###end p 17
###begin p 18
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 288 293 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
On chromosome 9, we identified a DNA fragment similar to the ESG1 gene that included two putative introns. These putative first and second exons, however, contained (4) multiple mutations of the ESG1 cDNA sequence. The putative third exon was identical to that of the previously reported ESG1 gene. Also on chromosome 9, we identified another DNA fragment that was similar, but not identical, to the third exon of the ESG1 gene. These findings suggest that these ESG1-like sequences on chromosome 9 have not been correctly assembled.
###end p 18
###begin p 19
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 748 749 748 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 890 895 890 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
To obtain DNA fragments containing the ESG1 gene, we screened the bacterial artificial chromosome (BAC) DNA pool by PCR using primer pairs that would only amplify the real gene, not the pseudogenes. We obtained two independent, but overlapping BAC clones. Southern blot analyses and sequencing demonstrated that these clones contained a sequence exhibiting complete identity with ESG1 cDNA that was interrupted by two putative introns (Figure 2A). The two intron sequences begin with GT and terminate with AG, fulfilling the GT-AG rule of exon-intron junctions [19]. The 5' flanking region of this DNA fragment exhibited strong promoter/enhancer activity by luciferase reporter assays in undifferentiated ES cells, but not in somatic cells (Figure 3). The same fragment showed much weaker activity after induction of differentiation by retinoic acid. We concluded that this sequence is the ESG1 gene.
###end p 19
###begin p 20
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">BAC clones containing the <italic>ESG1 </italic>gene and a duplication pseudogene (PS)</bold>
BAC clones containing the ESG1 gene and a duplication pseudogene (PS). A) Localization of the gene and PS on chromosome 9. B) Sequence comparison of the gene and PS revealed that these are homologous from eight base pairs upstream of the first exon to 675 bp downstream of the third exon. Substitution mutations are indicated by black lines. The insertion is indicated by an open triangle.
###end p 20
###begin p 21
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Promoter/enhancer activity of the <italic>ESG1 </italic>gene and pseudogene</bold>
Promoter/enhancer activity of the ESG1 gene and pseudogene. DNA fragments of ~6 kbp isolated from the 5' flanking regions of the gene and PS were transferred into luciferase reporter plasmids. We introduced the reporter genes into undifferentiated ES cells (open columns), retinoic acid-treated ES cells (grey columns), and NIH3T3 cells (closed columns). Data represent the averages and standard deviations of three independent experiments.
###end p 21
###begin p 22
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 279 284 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 719 720 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 983 988 983 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 994 996 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
We also found that the two BAC clones contained another ESG1-like sequence (Figure 2A). The two sequences, separated by a 68 kbp intergenic sequence, were oriented in opposite directions. The ESG1-like sequence exhibited greater than 95% identity to the exons and introns of the ESG1 gene. This sequence, however, contained critical nucleotide substitutions in all of the exons and one nucleotide insertion in exon 2 (Figure 2B). Although 675 base pairs of the 3' flanking regions were conserved between the ESG1 gene and the pseudogene, only five base pairs of the 5' flanking region were identical. This 5' flanking region (~6 kbp) did not possess any promoter/enhancer activity in luciferase reporter assays (Figure 3). It is thus unlikely that this sequence is transcribed or translated into a functional protein. This sequence likely represents a duplication pseudogene. Bierbaum previously reported the existence of two pseudogenes with similar exon-intron organization as the ESG1 gene [17]. We could not determine which of these two pseudogenes corresponds to the one we identified or the location of the remaining pseudogene.
###end p 22
###begin title 23
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Targeted disruption of the mouse ESG1 gene
###end title 23
###begin p 24
###xml 290 292 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 502 504 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
To study the function of ESG1, we deleted the gene by homologous recombination in mouse ES cells. We replaced the three exons with either a fusion of the neomycin-resistance and beta-galactosidase genes (beta-geo) or the hygromycin resistant gene (HygR) using two targeting vectors (Figure 4A) introduced into RF8 ES cells by electroporation. We obtained eight ES cell clones with correct homologous recombination of the beta-geo targeting vector, which was confirmed by Southern blot analysis (Figure 4B). We obtained only one clone with correct homologous recombination of the HygR targeting vector.
###end p 24
###begin p 25
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Targeted disruption of the mouse ESG1 gene</bold>
###xml 137 140 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pst</italic>
###xml 150 153 150 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spe</italic>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Targeted disruption of the mouse ESG1 gene. A) Targeting strategy. Homologous regions are indicated by thick lines. Recognition sites of PstI (P) and SpeI (S), which were used for Southern blot analyses, are shown. The gene encoding diphtheria toxin A (DTA) was inserted at the 3' end of the targeting vectors to facilitate negative selection. B) Southern blot analyses confirming homologous recombination. WT, wild-type ES cells; beta, beta-geo +/- ES cells; H, HygR +/- ES cells; -/-, ESG1-null ES cells. Numbers indicate clone numbers. C) Northern blot (upper) and western blot (lower) analyses of wild-type ES cells (WT), ESG1-null ES cells (-/-, three clones) and heterozygous ES cells (+/-). Northern blot was performed as previously described [20]. To confirm the loading of equal amounts of RNA, ethidium bromide staining of ribosomal RNA is also shown (middle).
###end p 25
###begin p 26
###xml 167 172 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 275 277 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
To obtain homozygous mutant ES cells, we introduced the beta-geo vector into HygR heterozygous ES cells. Of 105 G418-resistant colonies tested, 49 were homozygous for ESG1 deletion. Northern blot and western blot analyses confirmed the absence of ESG1 in these cells (Figure 4C). In 29 clones, the beta-geo vector had replaced the HygR vector, such that the cells remained heterozygous. In the remaining 27 clones, the beta-geo vector was integrated at non-homologous sites.
###end p 26
###begin p 27
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 185 189 185 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 357 366 <span type="species:ncbi:10090">nude mice</span>
ESG1-/- ES cells exhibited normal morphology (Figure 5A). These cells also proliferated at a speed comparable to that of the control (heterozygous and wild-type) cells (Figure 5B). ESG1-/- cells differentiated normally after the removal of leukemia inhibitory factor (Figure 5B) or retinoic acid treatment (not shown). When transplanted into hind flanks of nude mice, these cells produced teratomas, tumors containing components of all three germ layers (Figure 5C). These results indicate that ESG1 is dispensable for the self-renewal properties and pluripotency of ES cells.
###end p 27
###begin p 28
###xml 0 30 0 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analyses of ESG1-null ES cells</bold>
###xml 209 211 209 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
Analyses of ESG1-null ES cells. A) The morphology of ESG1-null ES cell colonies grown on STO feeder cells. B) Growth curve of wild-type (WT), ESG1-null (-/-) and heterozygous (+/-) ES cells. Each clone (1 x 104 cells/well) was plated in 24-well plates. Cell numbers were determined with a Coulter counter at 2, 4, and 6 days. Data of +/- and -/- cells are shown as averages and standard deviations of three independent clones. C) A section of teratoma derived from ESG1-null ES cells (hematoxylin & eosin staining).
###end p 28
###begin p 29
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 48 52 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 238 242 238 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 312 318 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nanog </italic>
###xml 322 328 322 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oct3/4</italic>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 348 352 348 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 526 530 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 530 534 530 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 605 609 605 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 609 613 609 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 630 670 630 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Krt1-8, Pem, Ctgf, Ptgs2, Igf2 and Inhba</italic>
We examined the gene expression profiles of ESG1-/- ES cells using oligonucleotide-based DNA microarrays representing ~20,000 genes. In comparison to control ES cells, ESG1 was identified as the gene reduced to the greatest extent in ESG1-/- ES cells (Figure 6A). The expression of ES cell marker genes, such as Nanog and Oct3/4, was normal in ESG1-/- ES cells. We confirmed normal Oct3/4 expression at protein levels by Western blot (Figure 6B). The overall gene expression profiles were similar between control ES cells and ESG1-/- ES cells. Several genes exhibited a greater than two-fold reduction in ESG1-/- cells, including Krt1-8, Pem, Ctgf, Ptgs2, Igf2 and Inhba. These genes might be regulated directly or indirectly by ESG1. Since ESG1 contains a KH-type RNA-binding domain, it may stabilize mRNA of these genes. Further studied are required to clarify this possibility.
###end p 29
###begin p 30
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gene expression analyses of ESG1-null ES cells</bold>
###xml 344 348 344 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 356 360 356 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 213 218 <span type="species:ncbi:10090">Mouse</span>
Gene expression analyses of ESG1-null ES cells. A) DNA microarray analyses. Total RNA from wild-type ES cells and ESG1-null ES cells were labeled with Cy3 and Cy5, respectively. Samples were hybridized to Agilent Mouse Developmental Microarrays. The averages of two independent clones are shown. B) Western blot analyses. Cell lysates from ESG1+/- and ESG1-/- cells were examined for expression of ESG1, Oct3/4 and CDK4 with immunoblotting.
###end p 30
###begin p 31
###xml 53 57 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 57 61 54 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 178 182 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 182 186 179 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 233 237 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 237 240 234 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 249 253 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 253 256 250 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 279 283 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 283 287 280 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 535 540 <span type="species:ncbi:10090">mouse</span>
To generate ESG1-knockout mice, we injected beta-geo-ESG1+/- ES cell clones into the blastocysts of C57BL6 mice. We obtained germline transmission from three clones. We obtained ESG1-/- mice at the Mendelian ratios (36 wild-type, 69 ESG1+/-, and 45 ESG1-/-) from intercrosses of ESG1+/- mice. These animals exhibited normal development, gross appearance, and fertility (not shown). Histological examination of testis and ovary could not identify any abnormalities (not shown). These data demonstrated that ESG1 is dispensable for both mouse development and germ cell formation.
###end p 31
###begin p 32
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 76 80 76 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 94 98 94 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1</italic>
###xml 167 170 167 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
We also generated ES cells from blastocysts obtained by intercrosses of ESG1+/- males and ESG1-/- females. Of the eight ES cell lines established, two clones were ESG1-/-. These ESG1-null ES cells demonstrated normal morphology, proliferation, and differentiation (not shown), confirming that ESG1 is dispensable in ES cells.
###end p 32
###begin title 33
Conclusion
###end title 33
###begin p 34
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
###xml 277 282 <span type="species:ncbi:10090">mouse</span>
To analyze the physiological roles of ESG1, we identified the mouse gene on chromosome 9 and deleted it by homologous recombination in ES cells. Despite specific expression in early embryos, germ cells, and pluripotent cells, our data demonstrated that ESG1 is dispensable for mouse development, germ cell formation, and ES cell self-renewal.
###end p 34
###begin title 35
Methods
###end title 35
###begin title 36
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Identification and analyses of BAC clones containing the mouse ESG1 gene
###end title 36
###begin p 37
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 695 700 695 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
To identify bacterial artificial chromosome (BAC) clones containing mouse ESG1 gene, we performed PCR-based screening of mouse BAC library DNA pools (Research Genetics) using the pH34-u38 (5'-GAAGTCTGGTTCCTTGGCAGG-3') and pH34-L394 (5'-ACTCGATACACTGGCCTAGC-3') primers. Following restriction enzyme digestion, we performed Southern blot analyses of BAC clones as described [20] using the pH34-U258 (5'-CTCGAGTGTACAGTCAAGTGGTTGCTGGGA-3'), pH34-U65 (5'-GTGACCCTCGTGACCCGTAA-3'), pH34-intron1L (5'-CTGCGTGAGAGAAACACCAAACAGGC-3'), pH34-L545 (5'-TGTGAATGGGAAGGTTACCACTCT-3') and pH34-SCL1 (5'-GCCCTCTTCTGGTTTGTCTCGAAAT-3') probes. Hybridization with these probes revealed bands containing either the ESG1 gene or pseudogenes.
###end p 37
###begin p 38
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hind</italic>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR</italic>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 344 347 344 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BamH</italic>
###xml 403 406 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pst</italic>
###xml 542 547 542 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 795 798 795 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nsi</italic>
###xml 819 822 819 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 826 829 826 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spe</italic>
###xml 833 837 833 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR</italic>
###xml 845 848 845 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pst</italic>
###xml 987 992 987 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 1035 1038 1035 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
To sequence the region containing the mouse ESG1 gene and the 3' flanking region, we subcloned a ~15 kbp XhoI-SalI fragment into the pZERO-2 vector (Invitrogen). HindIII- or EcoRI-digested fragments of this vector were then cloned into pBluescript KS(-) for sequencing. To sequence the ESG1 pseudogene and the 3' flanking region, an 8 kbp NotI/XhoI fragment was cloned into pBluescript KS(-). BamHI- or PstI- fragments of this vector were also cloned into pBluescript KS(-). To identify the sequence containing the 5' flanking regions of the ESG1 gene and the related pseudogenes, we used a TOPO walker kit (Invitrogen) with the pH34-T2L (5'-ACTAGTCGCAGCAGGGATCCAGGAATATCT-3') and pH34-L394 primers. The resulting sequence was cloned into pCR2.1 (Invitrogen). We obtained a ~6 kbp band from the NsiI-digensted library; XbaI-, SpeI-, EcoRI-, and PstI-digested fragments of this band were cloned into pBluescript KS(-) for sequencing. This fragment contained the 5' flanking region of the ESG1 gene. A ~3 kbp fragment, obtained from the SacI-digested library, was cloned into pCR2.1 for sequencing. This fragment was contained the 5' region flanking the pseudogene.
###end p 38
###begin title 39
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
Construction of ESG1 targeting vectors
###end title 39
###begin p 40
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESG1 </italic>
###xml 106 108 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 703 706 697 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 767 769 761 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 783 785 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
We replaced all of the ESG1 exons with two targeting vectors containing either an IRES-beta-geo cassette [21] or an IRES-HygR cassette by promoter trap selection. We amplified the 5' arm (1.8 kbp) using KOD plus (TOYOBO) with the pH34-targetpair5-U (5'-CCGCGGAAAGTCAAGAGATTGGGTGG-3') and pH34-targetpair5-L (5'-GCGGCCGCCTTTACGGGTCACGAGGGTCAC-3') primers. The 3' arm (5.8 kbp) was amplified using the pH34-targetpair3-U (5'-TGTGGCCAGTGTTTGGTTCTGGCGGG-3') and pH34-targetpair3-L (5'-CTCGAGGACTCGCCATTCTAGCCAAG-3') primers. The IRES beta-geo or IRES HygR cassettes were ligated in between the two PCR fragments. The diphtheria toxin A cassette was placed downstream of the 3' arm. After linearization with SacII, these targeting vectors were electroporated into 2.0 x 107 RF8 ES cells [22] using a Gene pulser (BIORAD). Transfected cells were selected with 250 mug/mL G418 or 100 mug/mL hygromycin B, respectively. Genomic DNA from G418- or hygromycin B-resistant colonies was screened for homologous recombination by Southern blotting.
###end p 40
###begin title 41
Southern blot screening for homologous recombination
###end title 41
###begin p 42
###xml 164 167 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pst</italic>
###xml 258 260 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
ES cells genomic DNA was extracted with PUREGENEtrade mark Cell Lysis Solution (Gentra systems). For 5' Southern blot analysis, genomic DNA was first digested with PstI, then separated on an 0.8% agarose gel and transferred to a nylon membrane as described [20]. A 560 bp 5' probe was amplified using the ESG1S5 (5'- GATGGTGGTGGTGACTCAGAG -3') and ESG1AS5 as (5'- CCTCCATTGCCTCTATATCAG -3') primers. The probe specifically labeled an 18 kbp band from the wild-type locus, a 15 kbp band from the beta-geo locus, and a 12 kbp band from the HygR locus. Genomic DNA was also digested with SpeI for 3' Southern blot analysis. A 1,010 bp 3' probe was amplified with the pH34U-8000 (5'- CCAACCAGCCAGAGTTTCAGTTAT -3') and pH34L-9000 (5'-GATAAGCTGCTGCCAAAAGACAAG -3') primers. The probe hybridized to an 11.5 kbp band from the wild-type locus, a 12.5 kbp band from the beta-geo locus, and a 9.5 kbp band from the HygR locus.
###end p 42
###begin title 43
Generation of anti-ESG1 polyclonal antibodies
###end title 43
###begin p 44
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg1 </italic>
###xml 423 431 423 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 423 430 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 764 771 <span type="species:ncbi:9986">rabbits</span>
The coding sequence of Esg1 was amplified by PCR with the pH34-gw-s (5'- AAAAAGCAGGCTGGATGATGGTGACCCTCGTGA-3') and pH34-gw-as (5'- AGAAAGCTGGGTCTGCATCCAGGTCGGAGACA-3') primers. To construct pDONR-pH34, the resulting PCR product was subcloned into pDONR201 (Invitrogen). pDONR-pH34 was interacted with pDEST17 (Invitrogen) by LR recombination. After introduction of the resulting expression vector pDEST17-pH34 into BL21-AI E. coli (Invitrogen), recombinant protein production was induced according to the manufacture's protocol. Histidine-tagged ESG1 was purified using Ni-nitrilotriacetic acid agarose (Qiagen) under denaturing conditions in the presence of 8 M urea. After dialysis against 6 M urea, the recombinant proteins were injected into New Zealand White rabbits to generate anti-ESG1 polyclonal antibodies.
###end p 44
###begin title 45
Western blot
###end title 45
###begin p 46
###xml 402 413 <span type="species:ncbi:3704">Horseradish</span>
###xml 441 447 <span type="species:ncbi:9986">rabbit</span>
###xml 457 462 <span type="species:ncbi:10090">mouse</span>
After preparation of ES cell extracts with M-Per (Pierce), cellular proteins were separated on sodium dodecyl sulfate (SDS)-14% polyacrylamide gels and transferred to nitrocellulose membranes (Millipore). Membranes were incubated with anti-ESG1 (1/500 dilution), anti-Oct3/4 (1/500; Santa Cruz Biotechnology), anti-CDK4 (1/200; Santa Cruz Biotechnology), and anti-GFP (1/1000; MBL) primary antibodies. Horseradish peroxidase-conjugated anti-rabbit and anti-mouse immunoglobulins (1/5000; Cell Signaling) were used to detect antibody binding. We visualized bound antibody with an ECL Western Blotting Detection System (Amersham).
###end p 46
###begin title 47
Derivation of ESG1-deficient ES cells from blastocysts
###end title 47
###begin p 48
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esg1</italic>
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 7 14 7 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">or ESG1</italic>
###xml 14 18 14 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 337 343 <span type="species:ncbi:9913">Bovine</span>
Esg1+/-or ESG1-/- mutant female mice were injected with Tamoxifen (10 mug) and Depo-provera (1 mg) subcutaneously on the third day of pregnancy. Four days later, embryos in diapause were flushed out of the uterus and cultured on STO feeder cells in four-well plates in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 20% Fetal Bovine Serum (Hyclone), 0.1 mM Non-Essential Amino Acids (Invitrogen), 2 mM L-glutamine (Invitrogen), 50 U/ml Penicillin-Streptomysin (Invitrogen), and 0.11 mM 2-mercaptoethanol (Invitrogen). After six days, the central mass of each explant was harvested, rinsed in PBS, and placed in a drop of trypsin for a few minutes. The cell mass was collected with a finely drawn-out Pasteur pipette preloaded with medium, ensuring minimal carryover of the trypsin. The cells were gently transfered into a fresh well with 20% FBS-containing medium. The resulting primary ES cell colonies were individually passaged into wells of four-well plates containing STO feeder cell layers. Thereafter, cells were expanded by trypsinization of the entire culture.
###end p 48
###begin title 49
Microarrays
###end title 49
###begin p 50
###xml 42 46 42 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 132 137 <span type="species:ncbi:10090">Mouse</span>
Total RNA from wild-type ES cells and ESG1-/- ES cells was labeled with Cy3 and Cy5, respectively. The samples were hybridized to a Mouse Development Microarray (Algilent) according to the manufacturer's protocol. Arrays were scanned with a G2565BA Microarray Scanner System (Agilent). Hybridization was repeated with two independent clones. Data were analyzed with GeneSprings software (Silico Genetics).
###end p 50
###begin title 51
Authors' contributions
###end title 51
###begin p 52
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 191 196 <span type="species:ncbi:10090">mouse</span>
HA carried out the phenotypic studies of ESG1 knockout mice. KI determined the chromosomal localizations of the ESG1 gene and pseudogenes and constructed the targeting vector. TI carried out mouse embryo manipulation. MM and MN carried out ES cell culture. SY conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
We thank Chihiro Takigawa, Junko Iida, Masako Shirasaka, Yumi Ohuchi, and Megumi Narita for their technical and administrative assistance. We are grateful to Drs. Minoru Ko and Azim Surani for sharing helpful data prior to publication, Dr. Hitoshi Niwa for generously providing various vectors, and Dr. Robert Farese Jr. for his kind gift of the RF8 ES cells. This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Uehara Memorial Foundation, the Naito Foundation, the Sumitomo Research Foundation, the Mitsubishi Foundation. S.Y. was supported by a Toray Science and Technology Grant (to S.Y.). This work was also supported in part by a Grant-in-Aid for 21st Century COE (Center of Excellence) Research from the Ministry of Education, Culture, Sports, Science, and Technology.
###end p 54
###begin article-title 55
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Establishment in culture of pluripotential cells from mouse embryos
###end article-title 55
###begin article-title 56
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells
###end article-title 56
###begin article-title 57
###xml 39 44 <span type="species:ncbi:9606">human</span>
Embryonic stem cell lines derived from human blastocysts
###end article-title 57
###begin article-title 58
Self-renewal of teratocarcinoma and embryonic stem cells
###end article-title 58
###begin article-title 59
Embryonic stem cells: prospects for developmental biology and cell therapy
###end article-title 59
###begin article-title 60
Regulatory networks in embryo-derived pluripotent stem cells
###end article-title 60
###begin article-title 61
Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity
###end article-title 61
###begin article-title 62
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei
###end article-title 62
###begin article-title 63
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development
###end article-title 63
###begin article-title 64
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Role of ERas in promoting tumour-like properties in mouse embryonic stem cells
###end article-title 64
###begin article-title 65
###xml 70 75 <span type="species:ncbi:10090">Mouse</span>
The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells
###end article-title 65
###begin article-title 66
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
Differential roles for sox15 and sox2 in transcriptional control in mouse embryonic stem cells
###end article-title 66
###begin article-title 67
###xml 60 66 <span type="species:ncbi:10090">murine</span>
Changes in gene expression following exposure of nulli-SCCl murine embryonal carcinoma cells to inducers of differentiation: characterization of a down-regulated mRNA
###end article-title 67
###begin article-title 68
###xml 130 135 <span type="species:ncbi:9606">Human</span>
Analysis of Esg1 Expression in Pluripotent Cells and the Germline Reveals Similarities with Oct4 and Sox2 and Differences Between Human Pluripotent Cell Lines
###end article-title 68
###begin article-title 69
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Generation of pluripotent stem cells from neonatal mouse testis
###end article-title 69
###begin article-title 70
The KH domain occurs in a diverse set of RNA-binding proteins that include the antiterminator NusA and is probably involved in binding to nucleic acid
###end article-title 70
###begin article-title 71
Cloning of embryonal stem cell-specific genes: characterization of the transcriptionally controlled gene esg-1
###end article-title 71
###begin article-title 72
Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification
###end article-title 72
###begin article-title 73
Organization and expression of eucaryotic split genes coding for proteins
###end article-title 73
###begin article-title 74
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile
###end article-title 74
###begin article-title 75
Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression
###end article-title 75
###begin article-title 76
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals
###end article-title 76

